Transfusion-dependent Non-severe Aplastic Anemia
5 clinical trials · Condition
◉ Watch Transfusion-dependent Non-severe Aplastic Anemia
| Record | Firm | Date |
|---|---|---|
| CsA+EPAG/HPAG+Romiplostim N01 in the Treatment of Newly-diagnosed SAA/TD-NSAA (NCT07523009) | Peking Union Medical College Hospital | 2026-06-01 |
| Enarodustat+CsA vs CsA in the Treatment of Newly-diagnosed TD-NSAA (NCT07522996) | Peking Union Medical College Hospital | 2026-06-01 |
| Enarodustat + CsA vs CsA in Newly Diagnosed TD-NSAA (NCT07548671) | Peking Union Medical College Hospital | 2026-04-01 |
| CsA+EPAG/HPAG+Romiplostim N01 in Newly-diagnosed SAA/TD-NSAA (NCT07558434) | Peking Union Medical College Hospital | 2026-04-01 |
| Treatment of Transfusion-dependent Nonsevere Aplastic Anemia With Luspatercept: a Multicenter Prospective Clinical Study (NCT06964971) | The First Affiliated Hospital of Zhejiang Chinese Medical University | 2025-05-20 |
Track Transfusion-dependent Non-severe Aplastic Anemia automatically
Every clearance here is in the API, with alerts when new ones post.